Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Inactive
Last updated: July 30, 2025
Recombinant Anti-Mullerian Hormone
Inactive
Last updated: June 24, 2025
UPA IUS

Ulipristal Acetate (UPA) Intrauterine System (IUS)

Inactive
Last updated: June 20, 2025
Acyline

GnRH II Receptor Antagonists

Inactive
Last updated: May 30, 2025
PCL Microspheres Encapsulating LNG + EE
Inactive
Last updated: May 30, 2025
Subtilosin
Inactive
Last updated: May 29, 2025
ORAL T-8

Oral Testosterone Male Contraceptive

Inactive
Last updated: May 29, 2025
NOMAC Vaginal Ring
Inactive
Last updated: May 29, 2025
Nestorone®/Estradiol Transdermal Gel

Nestragel

Inactive
Last updated: May 29, 2025
Injectable PLGA Microspheres with GES + EE
Inactive
Last updated: May 29, 2025
Single-Rod Gestodene Implant